F.D.A. Delays Action on Closely Watched Alzheimer’s Drugnews2024-03-08T11:45:07+00:00March 8th, 2024|The New York Times|
¿Se puede tener alzhéimer y no presentar síntomas?news2024-03-06T15:35:15+00:00March 6th, 2024|The New York Times|
Apparently Healthy, but Diagnosed With Alzheimer’s?news2024-03-04T17:25:50+00:00March 4th, 2024|The New York Times|
Trump’s Takeover of the Republican Partynews2024-02-15T17:38:23+00:00February 15th, 2024|The New York Times|
What to Know About Mild Cognitive Impairment Treatmentnews2024-02-06T17:44:41+00:00February 6th, 2024|The New York Times|
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelmnews2024-01-31T19:10:58+00:00January 31st, 2024|The New York Times|
Un esperanzador experimento de ultrasonido para los tratamientos del cerebronews2024-01-17T08:00:22+00:00January 17th, 2024|The New York Times|
An Ultrasound Experiment Tackles a Giant Problem in Brain Medicinenews2024-01-10T10:01:37+00:00January 10th, 2024|The New York Times|
Scientists Investigating Alzheimer’s Drug Faulted in Leaked Reportnews2023-10-14T17:25:41+00:00October 14th, 2023|The New York Times|
New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Declinenews2023-07-17T14:30:32+00:00July 17th, 2023|The New York Times|
